Rasburicase in Tumor Lysis Syndrome
The purpose of this study is to determine whether rasburicase is effective and safety in correcting hyperuricemia.
Hyperuricemia
DRUG: Rasburicase
Percentage of patients with uric acid greater-than-normal laboratory levels (hyperuricemia), 24-48 hours after last dose of rasburicase|Percentage of patients with uric acid greater-than-normal laboratory levels (hyperuricemia), 28 (+- 3) days after the last dose of rasburicase|Adverse events occurrence, During the study
The purpose of this study is to determine whether rasburicase is effective and safety in correcting hyperuricemia.